Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study Luc F. Van Gaal , Aila Rissanen , André Scheen +2 more 2005 The Lancet 1486 citations